Skip to main content

Mohamedtaki Tejani, MD, FACS

Mohamedtaki Tejani, MD, FACS

Medical Oncologist

Cancer

Tejani

Overview

Mohamedtaki A. Tejani, MD, received his Bachelor of Arts degree, Magna Cum Laude, from Amherst College. He later earned his medical degree from Dartmouth Medical School. Dr. Tejani went on to complete his residency at Yale-New Haven Hospital in New Haven, CT, achieving the rank of Chief Resident. Following this, he completed his fellowship training in hematology/oncology at Fox Chase Cancer Center/Temple University in Philadelphia. An award-winning physician, Dr. Tejani has authored numerous oncology-related publications. His research experience and areas of interest include gastrointestinal cancers, biomarkers and therapeutics, patient-provider communication and the culture of medicine. Dr. Tejani firmly believes that patient care is a privilege. Listening and responding to a patient’s unique story is critical in helping that family on their cancer journey. Originally from Tanzania (East Africa), he is fluent in Swahili, Hindi, Urdu and Gujarati.

Articles

Associations of Uncertainty With Psychological Health and Quality of Life in Older Adults With Advanced Cancer

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

2021

Comparing Needles and Methods of Endoscopic Ultrasound-Guided Fine-Needle Biopsy to Optimize Specimen Quality and Diagnostic Accuracy for Patients With Pancreatic Masses in a Randomized Trial

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY

2021

DKN-01 in combination with tislelizumab and chemotherapy as a first-line therapy in unselected patients with advanced gastroesophageal adenocarcinoma (GEA): DisTinGuish trial

ANNALS OF ONCOLOGY

2021

A phase I dose escalation study of eryaspase in combination with modified FOLFIRINOX in locally advanced and metastatic pancreatic ductal adenocarcinoma.

JOURNAL OF CLINICAL ONCOLOGY

2021

Adjuvant Chemotherapy Use in Patients With Locally Advanced Rectal Cancer: A Single-Institution Experience

CLINICAL COLORECTAL CANCER

2020

Detection of Circulating Tumor DNA in Plasma: A Potential Biomarker for Esophageal Adenocarcinoma

ANNALS OF THORACIC SURGERY

2019

Opportunities for cannabis in supportive care in cancer

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY

2019

Bemarituzumab with modified FOLFOX6 for advanced FGFR2-positive gastroesophageal cancer: FIGHT Phase III study design

FUTURE ONCOLOGY

2019

Wireless transcutaneous electrical nerve stimulation device for chemotherapy-induced peripheral neuropathy: an open-label feasibility study

SUPPORTIVE CARE IN CANCER

2019

Short course radiation therapy for rectal cancer in the elderly: can radical surgery be avoided?

JOURNAL OF GASTROINTESTINAL ONCOLOGY

2019

Education & Training

Education

University of Rochester School of Medicine, Rochester, NY

Residency

Yale-New Haven Medical Center, New Haven, CT

Fellowship

Fox Chase Cancer Center/Temple University, Philadelphia, PA